The system of rules, practices, and processes by which a corporation is directed and controlled.
On the exam, governance often shows up as a “which is the weakest/strongest governance feature” ranking item or a vignette listing several board facts. The answer usually hinges on separating monitoring from management: genuine board independence and oversight outrank cosmetic features like board size. The curriculum also flags entrenchment devices that insulate insiders from accountability, so weigh substance over what management calls “stability.”
The classic confusion is mixing up three related ideas. Governance is the system that resolves conflicts; shareholders are one stakeholder group—the residual claimants who vote—while stakeholders is the broader set whose competing interests governance must balance. Students wrongly equate “good governance” with “maximize shareholder value”: the curriculum teaches stakeholder management (consider every group), not pure shareholder primacy. Memory hook: governance is the referee, not a player—it manages the principal–agent conflict and stakeholder conflicts rather than siding with any one group.
Any group with an interest in the firm — shareholders, creditors, employees, customers, suppliers, regulators, and the community.
Questions often use a stakeholder-mapping grid, ranking a stakeholder by power × interest to spot the textbook conflict: shareholders favor risky, high-return projects while creditors (bondholders) prefer safety, because debt is paid first and gets none of the upside — the classic asset-substitution / risk-shifting problem. The “tell” is any vignette where a firm levers up, raises a special dividend, or takes on volatile projects: that transfers wealth from bondholders to shareholders, which protective bond covenants exist to curb.
Don’t blur the three terms. Shareholders are one stakeholder group — the equity-owning residual claimants — so every shareholder is a stakeholder, but not vice versa (creditors, employees, suppliers, regulators, the community count too). Governance is the mechanism that balances these competing claims, not a stakeholder itself. The frequent trap is calling a supplier or regulator a “shareholder”; on the CFA Institute Code, client interests rank above the employer’s and your own.
Holders of equity claims on a corporation — entitled to vote, receive declared dividends, and claim residual assets in liquidation.
The exam loves the liquidation waterfall: common shareholders are paid last, behind secured creditors, then priority unsecured claims (taxes and certain employee wages), then general unsecured creditors and preferred holders — so common equity is the residual claim, with theoretically unlimited upside but loss capped at the investment (limited liability). A favorite vignette tests cumulative versus straight (statutory) voting: cumulative lets a minority holder concentrate all votes on one director, improving minority board representation, while straight voting lets a bare majority elect the entire board. Watch for proxy voting (authorizing another to vote for you) and the ordinary versus special resolution split — the latter, e.g. a charter amendment or merger, typically needs a supermajority.
The classic trap is conflating shareholders with stakeholders — every shareholder is a stakeholder, but creditors, employees, and regulators are stakeholders without an equity claim or a vote. Don’t confuse shareholder rights (the entitlements) with governance (the system enforcing them). Hook: shareholders are the owners who eat last but keep whatever’s left over.
Funds and assets a firm uses to operate and invest; debt plus equity make up its capital structure.
Level I tests this two ways. First, plug-and-chug WACC: weight each source by its target (or market-value) proportion, never book value, and use the after-tax cost of debt r_d(1−t) while leaving the cost of preferred and common equity pre-tax. The classic traps are tax-shielding equity and pulling cost of debt from the coupon rate instead of the bond’s yield to maturity (the marginal cost of new debt). Second, conceptual MM questions: watch that adding leverage with taxes also raises the cost of equity (MM II), yet still lowers WACC.
The confusables: don’t conflate cost of capital with return — WACC is the firm’s required return (a hurdle), while a project’s IRR or expected return is what it delivers (see investment, where you accept only when expected return > WACC). And distinguish raising capital (issuance) from pricing it (this term). Memory hook: only debt gets the haircut — the government subsidizes interest, never dividends, so just the debt term carries (1−t).
A reduction in existing shareholders' ownership percentage when new shares are issued.
Exam items typically hand you net income, weighted-average basic shares, and a slate of convertibles or options, then ask for diluted EPS — the tell is that the answer hinges on the if-converted method for convertible bonds/preferred (add back after-tax interest, or preferred dividends, to the numerator and add the conversion shares to the denominator) and the treasury-stock method for options/warrants. The classic trap is the antidilutive screen: a security that would raise EPS is excluded, so the right answer is often a smaller adjustment than the brute-force calculation suggests. Out-of-the-money options are simply ignored.
Don’t confuse dilution with issuance, the broader act of raising capital — dilution is only the per-share-ownership consequence of issuing equity, not debt. Contrast it with a buyback: repurchases shrink the share count, but the EPS effect depends on financing — accretive only when the earnings yield exceeds the after-tax cost of the cash or debt used, otherwise dilutive. A memory hook for the EPS calc: “diluted is the conservative, lower number” — if a path pushes EPS up, it’s antidilutive and gets thrown out.
Deployment of capital into projects or assets expected to earn an adequate return — capital expenditures, acquisitions, and net working capital.
Expect a vignette that hands you cash flows and asks you to choose between mutually exclusive projects — the classic tell that NPV and IRR may rank them differently. The conflict traces to the reinvestment-rate assumption: NPV reinvests interim cash flows at the cost of capital, IRR at the (often unrealistic) IRR itself. Anchor on the crossover rate — where the two projects’ NPVs are equal; on either side the NPV ranking flips, with a conflict once the cost of capital sits below it. A second trap is non-conventional cash flows (more than one sign change), which can yield multiple IRRs or none, while NPV stays single-valued.
Keep capital budgeting (the accept/reject choice) distinct from cost of capital — the WACC hurdle is an input, not the output. And separate a project from a merger: an acquisition is one investment project, but exam M&A items turn on synergies and the takeover premium, not standalone NPV. Memory hook: when NPV and IRR fight, “Net” wins — NPV is the decision rule, IRR a return statistic.
The process of bringing new securities to market — equity, debt, or hybrid — to raise capital.
The exam rarely asks you to define issuance — it makes you match a financing need to the right method or rank financing choices. The tell is which feature dominates: speed and minimal disclosure point to a private placement or bank loan; protecting current shareholders points to a rights offering (existing holders buy new shares first, pro rata, often at a discount); a few-weeks horizon for a high-credit issuer flags commercial paper. The hinge is usually the pecking-order priority in the tip — internal funds, then debt, then equity last.
The classic trap is confusing issuance (raising new capital) with dilution and cost of capital. Issuing new equity raises capital but dilutes ownership; issuing debt raises capital without dilution but adds the after-tax cost that feeds WACC. A rights offering is the anti-dilution route — owners who exercise keep their percentage. Watch the terminology: CFAI calls a firm’s later equity sale a seasoned/follow-on offering (new shares, dilutive), whereas a true secondary offering is existing holders reselling old shares (no new capital, non-dilutive).
A repurchase of the firm's own shares, returning cash to shareholders and reducing the share count.
The classic item gives you cash, shares outstanding, and a repurchase price, then asks for the change in book value per share (BVPS): BVPS rises when the repurchase price is below the pre-buyback BVPS and falls when it is above — book value is the comparison line here, not market price or intrinsic value. The parallel EPS version is debt-funded; the tell is whether the after-tax cost of debt is below the earnings yield (E/P, the inverse of P/E). Watch the trap that higher EPS automatically means more value: it does not, because a shrinking share count, not higher earnings, drove the number.
A frequent distractor pits buyback against dividend: with no tax or signaling differences and a repurchase at fair market price, an equal-sized buyback and cash dividend leave shareholder wealth identical — only the form differs. Don’t conflate a buyback with reversing dilution: it cuts the count but doesn’t claw back value already transferred to option holders. Memory hook: buy low, build value — repurchasing under intrinsic value rewards the holders who stay.
Combinations of two or more firms into one, typically with the acquirer absorbing the target.
A common exam move is to match the deal to its motive or the regulator’s concern: a combination flagged for raising the Herfindahl–Hirschman Index (HHI) — the concentration screen regulators use — is horizontal; “securing input supply” is vertical; “diversifying across cycles” is conglomerate. A second pattern compares payment methods (light at Level I, deeper at Level II): a stock offer signals the acquirer thinks its own shares are richly valued and shares the deal’s risk and reward with target holders (now part-owners), whereas an all-cash offer keeps all post-deal risk and reward with the acquirer — the “tell” that management is confident.
Versus investment, the trap is treating an acquisition as plain positive-NPV capital budgeting; the point is that the control premium plus winner’s-curse overpayment can push the bid toward zero or negative NPV for the buyer, even for a “good” target. And don’t confuse mergers with spinoffs — the opposite direction of restructuring, splitting a unit into an independent company. Memory hook: cash = confident, stock = “I’d rather pay with paper I think is rich.”
Distribution of a subsidiary's shares to existing shareholders, creating an independent publicly-traded company.
Scenario items rarely ask you to define a spinoff; they hand you a vignette and make you name the form or predict the cash effect. The decisive tell is the cash flow: a spinoff and a split-off raise no cash for the parent, whereas an equity carve-out (minority IPO) and a divestiture/outright sale do generate cash. If the prompt mentions IPO proceeds or a sale price, it is not a pure spinoff. The other classic trap is the split-off: because shareholders tender parent shares to receive subsidiary shares, the parent’s outstanding share count shrinks (like a buyback) — in a spinoff there is no exchange, so the count is unchanged.
Do not conflate any of these with mergers/acquisitions, which are combinations bought at a premium that empirically often destroys acquirer value (the winner’s curse) — the opposite direction from a value-unlocking demerger. (The deeper M&A and restructuring mechanics sit in the Level II Corporate Restructuring reading.) Memory hook: spin-OFF = ship shares OFF for nothing; carve-OUT = carve cash OUT via IPO.